Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Par Pharmaceutical Companies, a developer of generic drugs and branded pharmaceuticals, has announced the resignation of Veronica Lubatkin, executive vice president and CFO, effective March 6, 2009, to pursue other professional opportunities.
Subscribe to our email newsletter
The company has also announced that Lawrence Kenyon will join Par on December 15, 2008 as executive vice president of finance and will assume the role of CFO on March 9, 2009.
Mr Kenyon joins from Alfacell where he served as president, CFO and corporate secretary since joining the company in 2006. Mr Kenyon will remain on the board of directors of Alfacell and, in this capacity, will also serve as acting president, CFO and corporate secretary until January 31, 2009.
Mr Kenyon has received a bachelor’s degree in accounting from the University of Wisconsin – Whitewater.